EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A scalable natural language processing framework for drug repurposing in chemotherapy-induced adverse events from clinical narrative records

Masami Tsuchiya, Mari Inoue, Yoshimasa Kawazoe, Kiminori Shimamoto, Tomohisa Seki, Shungo Imai, Hayato Kizaki, Emiko Shinohara, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki, Satoko Hori

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2025.116157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Masami Tsuchiya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Drug Informatics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. Hauptthemen laut MEDLINE: Drug Repositioning, Natural Language Processing, Electronic Health Records, Antineoplastic Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Science and Technology Agency, Società Italiana di Pediatria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningNatural Language ProcessingElectronic Health RecordsAntineoplastic AgentsNeoplasmsDrug-Related Side Effects and Adverse ReactionsHumansRetrospective StudiesFemaleMaleMiddle AgedAged

Stichwörter der Autor:innen

Adverse eventsDrug repurposingElectronic health recordsNatural language processing

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Drug Informatics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Artificial Intelligence and Digital Twin in Healthcare, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Department of Healthcare Information Management, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
  • Institute of Library, Information and Media Science, University of Tsukuba, 1-2, Kasuga, Tsukuba, Ibaraki 305-8550, Japan.
  • Division of Information Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5, Takayama, Ikoma, Nara 630-0192, Japan.
  • Division of Drug Informatics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. Electronic address: satokoh@keio.jp.

Förderung

  • Japan Science and Technology Agency
  • Società Italiana di Pediatria

Zitieren

APA

Tsuchiya, M., Inoue, M., Kawazoe, Y., Shimamoto, K., Seki, T., Imai, S., Kizaki, H., Shinohara, E., Yada, S., Wakamiya, S., Aramaki, E., & Hori, S. (2026). A scalable natural language processing framework for drug repurposing in chemotherapy-induced adverse events from clinical narrative records. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116157

Vancouver

Tsuchiya M, Inoue M, Kawazoe Y, Shimamoto K, Seki T, Imai S, et al. A scalable natural language processing framework for drug repurposing in chemotherapy-induced adverse events from clinical narrative records. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2025.116157

BibTeX
@article{Tsuchiya2026,
  author = {Tsuchiya, Masami and Inoue, Mari and Kawazoe, Yoshimasa and Shimamoto, Kiminori and Seki, Tomohisa and Imai, Shungo and Kizaki, Hayato and Shinohara, Emiko and Yada, Shuntaro and Wakamiya, Shoko and Aramaki, Eiji and Hori, Satoko},
  title = {A scalable natural language processing framework for drug repurposing in chemotherapy-induced adverse events from clinical narrative records},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2025.116157}
}
Kostenlos starten →